Effective 31 August 2026
Information provided
This website presents corporate information, research activities, services and development plans. It does not provide medical advice, clinical services or an offer of securities.
Research programmes
MK-1 and other proprietary research programmes are investigational. Scientific mechanisms and preclinical findings described on this website do not establish clinical safety, efficacy, regulatory approval or product availability.
Forward-looking information
Plans concerning the Innovation Park Muscat facility, future capabilities, partnerships and commercial development reflect current intentions. Implementation depends on the relevant agreements, approvals, resources and technical decisions.
Scientific references
External publications are linked for scientific context. Their inclusion does not imply authorship, endorsement or that the published results are results of Maak's proprietary programmes.
Intellectual property
Maak's name, visual identity, proprietary programme names and original website content may not be reproduced or used to imply endorsement without written permission.
Contact
Questions may be directed to info@maakbiotech.com.